Next |
home / stock / atos / atos message board
Subject | By | Source | When |
---|---|---|---|
Wow. No comments? | killrEngineer | investorshub | 06/28/2023 2:55:37 PM |
MomentumIts trading | 4MVault | investorshub | 06/26/2023 2:08:03 PM |
$ATOS Lets go go go go... Up up and away we go. | DrHarleyboy | investorshub | 06/26/2023 10:09:55 AM |
$ATOS bears and bulls | DrHarleyboy | investorshub | 06/26/2023 1:31:57 AM |
$ATOS MomentumIts gaining | willlbone | investorshub | 06/25/2023 2:39:32 AM |
$ATOS Price now last trade up | ttottip | investorshub | 06/23/2023 10:42:47 PM |
what do you make of this data? | ADVFN_abullman | investorshub | 06/23/2023 6:25:09 PM |
short squeeze signal | ttottip | investorshub | 06/22/2023 4:44:49 PM |
$ATOS got some short data | powerwalker | investorshub | 06/19/2023 7:54:14 PM |
where is the squeeze? | powerwalker | investorshub | 06/19/2023 5:39:36 AM |
$ATOS Good read | MuskVoice | investorshub | 06/19/2023 1:50:39 AM |
The now last trade up | Agreed | investorshub | 06/16/2023 8:05:47 PM |
Price now | the_aaardvark | investorshub | 06/14/2023 7:53:41 AM |
Price now last trade up | slugo1 | investorshub | 06/13/2023 11:49:20 AM |
got some short data | DrHarleyboy | investorshub | 06/09/2023 6:15:18 PM |
$ATOS Have a look at this | slugo1 | investorshub | 06/09/2023 2:34:09 PM |
MomentumIts now last trade up | Agreed | investorshub | 06/09/2023 4:41:53 AM |
Found an interesting article | ttottip | investorshub | 06/06/2023 9:45:26 PM |
$ATOS The gaining | slugo1 | investorshub | 06/04/2023 9:46:47 PM |
$ATOS MomentumIts trading last up | ttottip | investorshub | 06/04/2023 9:27:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, April 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare Collaborative™ today announced the initiation of a new study to evaluate Atossa’s proprietary (Z)-endoxifen in com...
SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced promising safety and efficacy data from the Company’s Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) clinical trial. The ...
Fully enrolled two Phase 2 studies with data from both expected in the second half of 2024 First patient dosed in new Phase 2 breast cancer prevention study Data from ongoing Phase 2 EVANGELINE study scheduled to be presented at 2024 AACR Annual Meeting Ended 2023 with $88...